We are live on ! Find out more
ACM

Ayrshire Capital Management Portfolio holdings

AUM $214M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+20.58%
3 Year Est. Return
+78.45%
5 Year Est. Return
+99.59%
10 Year Est. Return
AUM
$143M
AUM Growth
+$8.38M
Cap. Flow
-$3.28M
Cap. Flow %
-2.3%
Top 10 Hldgs %
40.63%
Holding
50
New
2
Increased
30
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
AJG icon
Arthur J. Gallagher & Co
AJG
+$2.95M
2
KLAC icon
KLA
KLAC
+$2.58M
3
LFUS icon
Littelfuse
LFUS
+$1.06M
4
AMZN icon
Amazon
AMZN
+$149K
5
ZTS icon
Zoetis
ZTS
+$117K

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$3.26M
2
SYK icon
Stryker
SYK
+$2.98M
3
UNH icon
UnitedHealth
UNH
+$2.16M
4
HD icon
Home Depot
HD
+$823K
5
JNJ icon
Johnson & Johnson
JNJ
+$521K

Sector Composition

Rank Sector Weight
1 Technology 28.18%
2 Healthcare 19.43%
3 Financials 16.29%
4 Consumer Staples 12.36%
5 Consumer Discretionary 12.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
26
Arthur J. Gallagher & Co
AJG
$66.5B
$2.97M 2.08%
+15,759
New +$2.95M
NKE icon
27
Nike
NKE
$59.7B
$2.94M 2.06%
25,159
+283
+1% +$28.5K
BAC icon
28
Bank of America
BAC
$433B
$2.82M 1.97%
85,108
+13
+0% +$448
KLAC icon
29
KLA
KLAC
$243B
$2.79M 1.95%
+73,950
New +$2.58M
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$805B
$1.19M 0.83%
3,103
JPM icon
31
JPMorgan Chase
JPM
$934B
$1.17M 0.82%
8,716
+344
+4% +$43.6K
ARCC icon
32
Ares Capital
ARCC
$14.2B
$1.03M 0.72%
55,978
+2,809
+5% +$52.8K
COP icon
33
ConocoPhillips
COP
$162B
$953K 0.67%
8,080
+267
+3% +$32.5K
QCOM icon
34
Qualcomm
QCOM
$169B
$941K 0.66%
8,561
+252
+3% +$29.5K
AMT icon
35
American Tower
AMT
$81.9B
$933K 0.65%
4,405
+241
+6% +$50.2K
AMGN icon
36
Amgen
AMGN
$235B
$881K 0.62%
3,354
+67
+2% +$18K
SSNC icon
37
SS&C Technologies
SSNC
$19.3B
$724K 0.51%
13,903
+823
+6% +$41.7K
WPC icon
38
W.P. Carey
WPC
$16.4B
$650K 0.46%
8,494
+333
+4% +$25K
CRM icon
39
Salesforce
CRM
$168B
$622K 0.44%
4,688
-445
-9% -$64.9K
GILD icon
40
Gilead Sciences
GILD
$178B
$464K 0.32%
5,400
DGRO icon
41
iShares Core Dividend Growth ETF
DGRO
$43.5B
$365K 0.26%
7,297
+562
+8% +$27.6K
MDY icon
42
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.8B
$358K 0.25%
809
SPGI icon
43
S&P Global
SPGI
$127B
$335K 0.23%
1,000
GBDC icon
44
Golub Capital BDC
GBDC
$3.43B
$268K 0.19%
20,348
-952
-4% -$12.5K
BRK.B icon
45
Berkshire Hathaway Class B
BRK.B
$1.06T
$263K 0.18%
852
ENB icon
46
Enbridge
ENB
$111B
$227K 0.16%
5,795
+74
+1% +$2.89K
SLQD icon
47
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
-7,100
Closed -$337K
SYK icon
48
Stryker
SYK
$126B
-14,692
Closed -$2.98M
VRSK icon
49
Verisk Analytics
VRSK
$24.4B
-19,128
Closed -$3.26M

Similar funds

Ayrshire Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Ayrshire Capital Management held 50 positions worth $143M, up 6.2% from $134M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ayrshire Capital Management's Q4 2022 filing shows 2 new, 30 increased, 9 reduced and 3 closed positions. Its largest new stake was Arthur J. Gallagher & Co: 15,759 shares worth $2.97M. The largest sale was Verisk Analytics, an estimated $3.26M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Ayrshire Capital Management's largest Q4 2022 buy was Arthur J. Gallagher & Co: 15,759 shares worth $2.97M.
  • Ayrshire Capital Management added most to Littelfuse in Q4 2022, an estimated $1.06M increase.
  • Ayrshire Capital Management's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $2.16M.
  • Ayrshire Capital Management fully exited Verisk Analytics in Q4 2022, selling an estimated $3.26M.
  • Ayrshire Capital Management's ten largest holdings make up 41% of its $143M portfolio in Q4 2022.
  • Ayrshire Capital Management opened 2 new positions and closed 3 in Q4 2022.
  • Ayrshire Capital Management's portfolio value rose 6.2% quarter-over-quarter to $143M.

Based on Ayrshire Capital Management's 13F filing for Q4 2022, filed 11 Jan 2023.